Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4874004
Max Phase: Preclinical
Molecular Formula: C24H35N3O8
Molecular Weight: 493.56
Molecule Type: Unknown
Associated Items:
ID: ALA4874004
Max Phase: Preclinical
Molecular Formula: C24H35N3O8
Molecular Weight: 493.56
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOC(=O)CCCCCCCOc1cccc(-c2cn([C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)nn2)c1
Standard InChI: InChI=1S/C24H35N3O8/c1-2-33-20(29)11-6-4-3-5-7-12-34-17-10-8-9-16(13-17)18-14-27(26-25-18)24-23(32)22(31)21(30)19(15-28)35-24/h8-10,13-14,19,21-24,28,30-32H,2-7,11-12,15H2,1H3/t19-,21-,22+,23+,24+/m1/s1
Standard InChI Key: VXGUQUDZSAVRRZ-AZKGINQHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 493.56 | Molecular Weight (Monoisotopic): 493.2424 | AlogP: 1.20 | #Rotatable Bonds: 13 |
Polar Surface Area: 156.39 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.33 | CX Basic pKa: | CX LogP: 1.77 | CX LogD: 1.77 |
Aromatic Rings: 2 | Heavy Atoms: 35 | QED Weighted: 0.24 | Np Likeness Score: 0.01 |
1. Tomašič T, Rabbani S, Jakob RP, Reisner A, Jakopin Ž, Maier T, Ernst B, Anderluh M.. (2021) Does targeting Arg98 of FimH lead to high affinity antagonists?, 211 [PMID:33340913] [10.1016/j.ejmech.2020.113093] |
Source(1):